v1
Faculty Opinions recommendation of Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
NobleIDNI4P47W28R65S78
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/CDF33DF1)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims